Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXF1SB
|
||||
| Drug Name |
1-(1-(3,5-dichlorophenyl)-3-phenylpropylidene)thiosemicarbazide
|
||||
| Synonyms |
CHEMBL406601
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H15Cl2N3S
|
||||
| Canonical SMILES |
NC(=S)N\\N=C(/CCc1ccccc1)\\c2cc(Cl)cc(Cl)c2
|
||||
| InChI |
InChI=1S/C16H15Cl2N3S/c17-13-8-12(9-14(18)10-13)15(20-21-16(19)22)7-6-11-4-2-1-3-5-11/h1-5,8-10H,6-7H2,(H3,19,21,22)/b20-15+
|
||||
| InChIKey |
SCXZQHUVAMQHQY-HMMYKYKNSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.